MBNL2 and myotonic dystrophy type 1: Given the high level of identities and to assess the potential of using MBNL overexpression as a therapeutic option for DM1, we chose to use human MBNL1 and MBNL2 (Supplemental Figure 1B) to test for the rescue of cardiac defects in the CUG960 heart model.